01Core principlesThe concepts and mechanisms needed to understand the subject.
Contralateral symmetrisation is an optional adjustment to the opposite breast after unilateral cancer surgery or reconstruction. The aim is a result that better fits the person’s priorities, which may concern bra fit, volume in clothing, nipple position or appearance without clothing. It does not treat the index cancer. Some people accept their existing asymmetry or prefer an external aid to another operation. Others value balancing highly and accept its additional wounds and recovery. The reconstructive discussion should make these preferences explicit rather than assume that an apparently uneven pair of breasts requires surgical correction.
The two breasts need to be assessed as shapes rather than compared by cup size alone. Similar volumes can have different skin envelopes, nipple heights or degrees of droop. A reconstructed breast may have a different base, projection or texture from the remaining natural breast. Reduction removes tissue and reshapes the larger side; mastopexy changes position and skin-envelope shape without making major volume reduction its principal aim. Augmentation can enlarge a smaller side but introduces implant considerations. Adjustment of a reconstructed flap or implant may sometimes address the problem more directly than operating on the opposite breast.
The target can change with healing and subsequent treatment. Early swelling, tissue settling, planned implant adjustments and radiotherapy can alter the treated side differently from the opposite breast. This makes timing a clinical and preference-sensitive choice. Immediate balancing can combine procedures and reduce an interval of mismatch. Staging permits reassessment after important changes, but involves another episode of care and time living with asymmetry. ABS/BAPRAS guidance supports consideration of immediate or delayed contralateral surgery with attention to the cancer-treatment sequence and the consequences of additional wound complications.
Key points
- Identify the mismatch before choosing an operation: reduction decreases volume and reshapes, mastopexy primarily raises and reshapes, and augmentation adds volume with device-related consequences. Either breast may need adjustment, and further surgery is optional.
- Compare immediate and staged symmetrisation around the cancer plan, tissue recovery and expected change. Additional wound complications can affect adjuvant treatment; radiotherapy and settling may alter the eventual target, without imposing a universal timing rule.
- A new unexplained contralateral lump needs diagnostic assessment before elective balancing. NICE recommends a suspected cancer pathway referral for an unexplained breast lump in a person aged 30 or over; an earlier normal surveillance image does not explain a new finding.
- Discuss independent harms to the operated breast, including scars, wound problems, nipple perfusion and sensation changes, and possible further procedures. Improvement does not guarantee exact or permanent symmetry.
- Balancing the remaining breast changes size or shape and leaves breast tissue. It is a different decision from contralateral risk-reducing mastectomy, and appropriate surveillance and symptom assessment continue.
- Review wound healing, nipple and skin viability, bleeding and infection before judging the cosmetic result. Record the eventual outcome against the patient’s original goal and discuss further adjustment only if wanted.
02Mechanisms and patternsImportant relationships and how to distinguish them.
A larger, lower breast may need both a reduction in tissue volume and a lift; similar-sized breasts with different nipple levels may be better matched by reshaping and mastopexy. Adding an implant to a breast that already has the desired volume may make the size mismatch worse. Ask which feature the patient wants changed and examine both sides before naming a procedure. The intended operation should follow the observed mismatch, not the assumption that every low nipple requires the same correction.
A concern described as an oversized natural breast may actually reflect an underfilled expander or a contour issue on the reconstructed side. Review what treatment has been completed and what further adjustment is already intended. The patient may reasonably prefer reduction of the opposite breast, alteration of the reconstruction or neither. Explaining both sides helps avoid a new wound that fails to address the source of dissatisfaction.
An incompletely healed mound, significant swelling, a planned implant exchange or expected radiotherapy-related change can make a final comparison premature. Describe the particular uncertainty and what review will help resolve it. Do not imply that every irradiated breast changes in the same way or that delaying guarantees a stable result forever. If an early balancing operation is considered, discuss the possibility that later change could require another adjustment.
An unexplained lump, a new suspicious skin change or a concerning nipple change should not be attributed to ordinary asymmetry without assessment. In a person aged 30 or over, an unexplained breast lump warrants the NICE suspected cancer pathway. Arrange prompt assessment through the breast service if the patient is already under its care and defer the elective symmetry decision while the finding is unresolved. The planned operation is not a substitute for diagnosing the abnormality first.
03Interpreting evidenceInformation, measurements and their limitations.
Consider the information, its meaning and its limitations before deciding what follows.
- 01
Bilateral morphology and treatment assessment - Why
- Assess volume, ptosis, nipple position and sensation, breast base dimensions, chest-wall asymmetry and skin quality, together with previous operations and radiotherapy. With consent, photographs can record the starting appearance and support comparison at follow-up.
- Interpretation and limitations
- These findings identify whether the problem is chiefly size, position, contour or an evolving reconstruction. Measurements support discussion but do not decide which difference matters to the patient. Review the existing operative records so an unfinished reconstruction is not mistaken for its final state.
- 02
Resolve new contralateral symptoms - Why
- Ask about and examine any new lump, nipple symptom or skin change before elective surgery. Arrange diagnostic breast assessment of an unexplained finding using the appropriate referral pathway, including the NG12 suspected cancer pathway for an unexplained breast lump at age 30 or over.
- Interpretation and limitations
- A recent surveillance mammogram does not replace assessment of a new symptom. Clinical findings and the breast service’s diagnostic results should be reconciled before the elective plan is resumed. A tissue diagnosis made incidentally during a reduction would come after an avoidable operation performed without a known diagnosis.
- 03
Check the applicable imaging and surveillance record - Why
- Review the patient’s previous breast diagnosis, remaining breast tissue, current surveillance plan and imaging dates. For delayed breast reconstruction assessment, the ABS/BAPRAS guide specifies contralateral mammography within the preceding 12 months.
- Interpretation and limitations
- That recommendation belongs to the delayed-reconstruction assessment population; it is not a universal instruction to obtain a new mammogram before every isolated uplift. The team should identify the appropriate surveillance or diagnostic requirement for this patient and resolve missing or abnormal results before proceeding.
- 04
Assess procedural risks and treatment sequence - Why
- Review wound-healing risks, previous scars, nipple sensation, medicines and other health factors with the surgeon and anaesthetic team. Establish whether chemotherapy, radiotherapy or further reconstruction is planned and what a postoperative complication would mean for that sequence.
- Interpretation and limitations
- A simultaneous operation may reduce separate attendances but adds another operated site that can develop problems. An individual plan balances those consequences against the burden of waiting. Use procedure-specific consent and perioperative protocols when an operation is chosen; the general symmetry principle does not specify a universal drug regimen or recovery interval.
04Applied reasoningWorked examples connecting principles to decisions.
01Worked caseSelect a lift for a position mismatchA 57-year-old has a healed unilateral reconstruction with no further adjuvant treatment or mound adjustment planned. The opposite breast has a similar volume but a lower nipple and more ptosis. She wants to retain the present size and improve nipple level and bra fit.+
- 1The surgeon examines both breasts upright, reviews the treatment record and confirms that position and skin-envelope shape, rather than excess volume, drive the mismatch. There is no new contralateral symptom or unresolved examination or imaging concern. The patient confirms that she does not want either breast enlarged.
- 2They compare a contralateral mastopexy with reduction, augmentation, adjustment of the reconstructed side and accepting the current appearance. A lift most directly addresses the lower nipple and ptosis while preserving the volume she likes. They discuss scars, wound healing, changed sensation, nipple perfusion and the possibility of residual asymmetry or further surgery.
- 3She chooses mastopexy after reviewing the proposed result and scar pattern. The team documents the agreed target and performs the planned procedure. At the early review the wound is closed, the nipple is viable and there is no expanding swelling or infection; these findings are recorded before judging the cosmetic outcome.
- 4At the later review she reports easier bra fitting and is satisfied with the improved nipple level. Mild residual contour asymmetry remains, which she prefers to accept. The clinician records this observed result and her decision against further adjustment, confirms the ongoing surveillance plan and gives a route for reporting new symptoms.
02Clinical caseReassess after the treated side changesA patient with unilateral implant reconstruction and a larger opposite breast expects chest-wall radiotherapy. She wants better balance but is willing to live with temporary asymmetry to reduce the likelihood of planning against a changing target.+
- 1The team explains that radiotherapy can affect the reconstruction and that immediate balancing remains an individual option with its own recovery and wound risks. Her priority is to make a later comparison after treatment and reconstruction review, so they agree to stage the elective symmetry operation. She receives a prosthesis discussion and a named reconstructive follow-up plan.
- 2After cancer treatment and sufficient recovery for reassessment, the planned review takes place. The reconstructed breast is firmer and sits differently from its earlier appearance. The surgeon assesses whether the treated side itself requires management before choosing how much to change the opposite breast, rather than reusing measurements taken before radiotherapy.
- 3Following review of the settled reconstruction, she chooses a contralateral reduction to address the remaining volume difference. The operation is completed and the subsequent wound visit documents satisfactory healing. At the later outcome consultation she is satisfied with the improved balance in clothing and understands that the two breasts still differ in feel. No universal post-radiotherapy waiting period or permanent match is inferred from this case.
03Clinical caseA new lump changes the purpose of assessmentA 62-year-old awaiting contralateral reduction reports a new discrete lump in that breast. Her last surveillance mammogram, five months earlier, was reported as normal. The lump remains unexplained on the reconstructive examination.+
- 1The surgeon pauses the elective reduction plan and arranges prompt diagnostic breast assessment through the cancer referral pathway. The patient is told why the recent normal surveillance result does not resolve a newly developed clinical finding. The lump is not simply included in a reduction specimen in the hope that postoperative histology will provide the answer.
- 2The breast service assesses the abnormality and the completed diagnostic work-up confirms a new malignancy. The diagnostic report is communicated to the patient and the reconstructive surgeon, with the relevant imaging and tissue results available to the breast multidisciplinary team. The clinical question has changed from balancing a healthy breast to planning treatment of the new cancer.
- 3The elective booking is removed and a cancer-treatment consultation is completed, including discussion of how its options may affect future reconstruction and symmetry. The patient can explain the reason for the change and knows the team responsible for her next appointment. Cosmetic planning will be reconsidered within that treatment pathway rather than allowed to precede it.
05Checking understandingVerify the reasoning, revisit uncertainties and apply feedback.
- After reduction or mastopexy, assess wound healing, swelling, nipple and skin viability, pain and infection concerns through the operating service’s follow-up pathway. Significant bleeding, an expanding swelling, progressive redness or persistent worsening pain needs prompt clinical advice. If tissue perfusion is threatened, cosmetic assessment must wait while the surgical problem is addressed.
- Review the pathology of any removed tissue through the responsible team and communicate clinically significant results. Retain the operative record and relevant imaging so future clinicians understand the changes to each breast. The operation does not remove the need to assess a later new lump or skin change.
- At an appropriate healed-result review, compare the outcome with the specific goal agreed before surgery: volume in clothing, nipple level, comfort or another priority. Record residual differences and the patient’s view. Swelling at an early wound visit should not be mistaken for the final result, and further correction is an option rather than an obligation.
- Continue the applicable surveillance plan for remaining breast tissue. When an implant is introduced, give the patient its record and explain the follow-up and symptom advice appropriate to that device. Reassess later changes in shape or symptoms clinically rather than presuming that all changes are a harmless return of asymmetry.
06Special situationsVariants, exceptions and circumstances that change the usual approach.
Reduction and lift have different primary aims
Both can alter skin shape and nipple position, but volume removal is central to reduction. A patient who likes the existing breast size may prefer a lift when position is the main concern. The specific technique still depends on examination, tissue quality, scars and the agreed target.
Augmentation adds a different burden
An implant may help match a smaller side, but its possible infection, contracture, rupture and later revision consequences must be part of the comparison. The wish for symmetry alone does not establish that adding a device is preferable to adjusting the reconstruction or accepting a difference.
Risk reduction is a separate decision
A reduction or uplift leaves breast tissue and is not equivalent to risk-reducing mastectomy. If cancer anxiety or inherited risk motivates a request to remove the opposite breast, arrange an individual oncological and reconstructive discussion rather than treating mastectomy as a larger cosmetic balancing procedure.
Timing requires a named next step
A staged plan should identify what is being awaited, who will reassess and how the patient can return if circumstances change. Saying to wait until things settle without follow-up responsibility can leave a patient uncertain about whether reconstruction remains available or whether a new symptom needs attention.
07Common pitfallsFrequent interpretation and management errors.
- 01
Choosing an operation from cup size alone without assessing nipple position, ptosis, base shape, the state of the reconstruction and the patient’s preferred target.
- 02
Promising exact or permanent symmetry, or applying one fixed waiting interval regardless of tissue recovery, adjuvant treatment and the reason for staging.
- 03
Using a previous normal surveillance image to dismiss a new unexplained contralateral lump, or relying on elective reduction histology to provide its first diagnostic assessment.
- 04
Presenting surgery to the opposite breast as obligatory completion or cancer prevention, while omitting its independent wound, sensation and possible device-related consequences.